8-K: BioLargo Inc. Presents at Investor Webcast Conference

Sentiment:

Investor Presentation Disclosure


BioLargo, Inc. presented a slide deck at a webcast investor conference on May 14, 2024, which is now being filed with the SEC.

Summary

  • BioLargo, Inc. presented a slide deck at a webcast investor conference on May 14, 2024.
  • The presentation slides are included as Exhibit 99.1 in this SEC filing.
  • The company is not obligated to update the information in this report but may do so in the future.
  • The information in this report is not considered filed for liability purposes under the Securities Exchange Act of 1934 or the Securities Act of 1933.
  • The information is also not incorporated by reference into any other SEC filings.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a past event, with no clear positive or negative implications.

Risks

  • The company is not obligated to update the information in this report, which could lead to outdated information being available to investors.

Future Outlook

The company may update the information in the future through various channels, but is not obligated to do so.

Industry Context

This is a standard practice for publicly traded companies to disclose investor presentations via SEC filings.

Comparison to Industry Standards

  • Filing investor presentations as exhibits to 8-K forms is a common practice among publicly traded companies.
  • This ensures that all investors have access to the same information presented at investor conferences.
  • Many companies such as Clean Harbors, Inc. and Waste Management, Inc. also use 8-K filings to disclose investor presentations.

Stakeholder Impact

  • This filing ensures that all investors have access to the same information presented at the investor conference.

Key Dates

DateDescription
2024-05-14BioLargo, Inc. presented at a webcast investor conference at 1:30 PM Pacific Time.
2024-08-14Date of the 8-K filing with the SEC.

Keywords

investor conference, webcast, presentation, SEC filing, BioLargo

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.